BB-1701 has survived Eisai’s decision not to option the HER2-directed antibody-drug conjugate. | BB-1701 has survived Eisai’s ...

AZ and Daiichi are meanwhile continuing to explore new uses for the drug, and recently started dosing patients in DESTINY-Breast11, a phase III trial of Enhertu in neoadjuvant HER2-positive breast ...

The choice was Jonathan Brand, a 25-year-old righthander who finished last season with Double A Portland. Brand had been added to the major league roster before for Grapefruit League games but had ...

An antibody-drug conjugate like Enhertu. However, some patients may not be eligible for or cannot tolerate ADCs. So once a patient is eligible for chemotherapy, PELA would be a natural fit as our ...

I’ve spent a lot of time around pocket knives over the years, testing blades from many brands you’ve probably heard of—and a few you might not. And while I’ve only scratched the surface of ...

Not only are these ranked by capacity and performance, but we also dropped brands to the bottom that were legitimate fire hazards. In all, we recommend shopping for batteries on the bottom half of ...

Its breast cancer drug Trastuzumab Deruxtecan (brand name Enhertu), launched in January 2024, emerged as the top-selling new drug brand last year. According to IQVIA data, AstraZeneca had the ...

LOS ANGELES, March 06, 2025 (GLOBE NEWSWIRE) -- Lulu's Fashion Lounge Holdings, Inc. (“Lulus” or the “Company”) (Nasdaq: LVLU), the attainable luxury brand for women, is unveiling a bold new ...

Is Kisqali available as a generic? Kisqali only comes as a brand-name drug. It’s not currently available in a generic version. A generic drug is an exact copy of the active drug in a brand-name ...